INHALED THERAPIES FOR TUBERCULOSIS AND OTHER INFECTIOUS DISEASE

Speakers

Under Construction.  Please visit in the near future for Speaker Information.

 

Profile Image
Rany Condos
Profile Image
Charles Daley
Profile Image
Timothy Corcoran
Screen Shot 2017-08-02 at 9.58.14 AM.png
Larry Schlesinger
Larry S. Schlesinger, MD is an internationally recognized authority in infectious diseases with a particular interest in tuberculosis and lung biology. He earned a BA in Biology from Cornell University and MD from Rutgers Medical School. He completed his residency in Internal Medicine at the University of Michigan and clinical and research fellowships in Infectious Diseases at UCLA. He joined the faculty at the University of Iowa in 1991 where he served as Fellowship Director for the Division of Infectious Diseases and Associate Chair of the Department of Medicine. He moved to the Ohio State University in 2002 where he served as Director of the Division of Infectious Diseases, Department of Internal Medicine until 2011 when he became first chair of Microbial Infection & Immunity. During his tenure he founded the Center for Microbial Interface Biology, a Board of Trustees approved university-wide center with a focus on infectious diseases of concern to public health. In 2017 he became President and CEO of Texas Biomedical Research Institute in San Antonio, TX.

Dr. Schlesinger is a leading physician scientist whose studies focus on the pathogenesis of tuberculosis and other airborne infectious agents that subvert lung immune mechanisms. His discoveries have led to greater insight into the unique attributes that soluble and cellular components of the innate immune system of humans bring to the microbe-host interface (with a focus on human macrophages), translating them into drug discovery platforms. He is a prolific scholar, having authored more than 170 peer-reviewed articles, served as editor of 2 books and has written several chapters in leading textbooks on tuberculosis and lung biology. He has been continually funded for nearly 30 years by the National Institutes of Health (NIH) and other federal agencies as well as private foundations such as the Bill & Melinda Gates Foundation.

He is a current NIH NIAID Council member, Fellow of the American Association for the Advancement of Science, Association of American Physicians and American Academy of Microbiology, and OSU’s 2011 Distinguished Scholar and 2105 COM Distinguished Professor.
Profile Image
Brian Robertson
JBs passport photo .jpg
Joyoti Basu
Dr. Joyoti Basu is currently Senior Professor and Chairperson of the Department of Chemistry, Bose Institute, India. She has been working in the area of Mycobacterium tuberculosis and its interaction with macrophages for over two decades. She has made significant contributions on understanding how M. tuberculosis subverts host immune defense mechanisms. Her work has been recognized by the Fellowship of India’s three premier science Academies. She has served as Associate Editor of Journal of Immunology and is currently an Academic Editor of PLoS One. She serves as member of the Programme Advisory Committees of the Science and Engineering Research Board, India and the Indian Council of Medical Research. She has reviewed ad-hoc grants of various international grant-giving organizations and reviewed manuscripts for top-ranking international journals such as Nature. Her current interests are focused on the role of epigenetic modifications in tuberculosis infection, focusing on microRNAs and histone modifications.
Profile Image
Sally-Ann Cryan
Profile Image
Mercedes Gonzalez-Juarrero
Profile Image
Sally Sharpe
JennyLam.jpg
Jenny Ka Wing Lam
Dr Jenny Lam is currently Associate Professor in the Department of Pharmacology and Pharmacy, The University of Hong Kong. Dr Lam received her degree in Pharmacy from The University of Nottingham, UK (2001). She completed her PhD in drug delivery ('Phosphorylcholine-based copolymer as synthetic vector for gene delivery') at the University of Nottingham (2006) under the supervision of Dr Snow Stolnik. Shortly afterwards, she was awarded the Maplethorpe Fellowship, continued her research in nucleic acid delivery and promoted pharmaceutical education in the Department of Pharmacy at King's College London, UK. In 2009, Dr Lam joined the University of Hong Kong. Her research is focused on the development of novel delivery system for macromolecular therapeutics including nucleic acids, proteins and peptides, and the use of antimicrobial peptides against respiratory infections. She is also interested in using spray drying and spray freeze drying technologies to produce inhaled powder formulation. She has published over 40 scientific articles in pharmaceutics. She is the principal investigator of a number of research projects funded by competitive grants.
Profile Image
Miriam Braunstein
Profile Image
Henderik Frijlink
Profile Image
Paolo Colombo
Profile Image
Amit Misra
Profile Image
Pavan Muttil
Profile Image
Igor Gonda
Profile Image
Nicolas Tsapis
Profile Image
Francesca Buttini
Profile Image
Anthony Hickey
Profile Image
Bernard Fourie
photo.jpg
Stefano Giovagnoli
Stefano Giovagnoli graduated in chemistry in 1997 at the University of Perugia, Italy. After being R&D scientist at Glaxo Wellcome, Ware, UK, he obtained his PhD in drug microencapsulation and delivery from the University of Perugia, Italy. He was recipient of the 2004 AAPS Outstanding Graduate Student Research Award in Pharmaceutical Technologies. He has been visiting PhD student and postdoc at the School of Pharmacy, University of Kentucky, Lexington, Kentucky. He is currently Associate Professor of Pharmaceutical Technology and Biotechnology at the Department of Pharmaceutical Sciences, University of Perugia. He serves as Board Editor of the Journal of Pharmaceutical Innovation and Journal of Medicinal Chemistry and Research and Review Editor of Frontiers in Pharmacology. He is member of the AAPS, Italian Chemical Society (SCI), AAPS Italian University Network (AItUN), ADRITELF and the Italian CRS chapter. He has about 100 presentations at international meetings, 70 publications, 2 book chapters and 3 patents.
Profile Image
Edward Nardell
Profile Image
Kenneth Olivier
Profile Image
Gail Cassell
Profile Image
Thomas Hofmann
Profile Image
Ruxandra Gref
Profile Image
Hak-Kim Chan
Top